凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业合计出资额5010万元

财中社12-16

财中社12月16日电凯赛生物（688065）发布公告，拟与创科生物及上海曜建共同投资设立曜酰生物技术(上海)合伙企业，合计出资额为5010万元。其中，公司出资2550万元，占比50.9%；创科生物出资2450万元，占比48.9%；上海曜建出资10万元，占比0.2%。设立的合伙企业将专注于生物基聚酰胺复合材料的研发、生产与销售。此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2491161514?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-16 20:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2491161514","market":"sh","top_or_hot":-1,"title":"凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元","media":"财中社","content":"<div>\n<p>财中社12月16日电凯赛生物（688065）发布公告，拟与创科生物及上海曜建共同投资设立曜酰生物技术(上海)合伙企业，合计出资额为5010万元。其中，公司出资2550万元，占比50.9%；创科生物出资2450万元，占比48.9%；上海曜建出资10万元，占比0.2%。设立的合伙企业将专注于生物基聚酰胺复合材料的研发、生产与销售。此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-16 20:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社12月16日电凯赛生物（688065）发布公告，拟与创科生物及上海曜建共同投资设立曜酰生物技术(上海)合伙企业，合计出资额为5010万元。其中，公司出资2550万元，占比50.9%；创科生物出资2450万元，占比48.9%；上海曜建出资10万元，占比0.2%。设立的合伙企业将专注于生物基聚酰胺复合材料的研发、生产与销售。此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688065","symbol_name":"凯赛生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b","article_id":"2491161514","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2491161514","pubTimestamp":1734352655,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对2024年度的经营业绩产生重大影响，且不损害上市公司及股东的利益。2024年前三季度，凯赛生物实现收入22.15亿元，归母净利润3.45亿元。文章来源：财中社凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688065":"凯赛生物","BK0208":"化学纤维"},"translate_title":"Cathay Biotech plans to jointly invest with Chuangke Biotech and Shanghai Yaojian to establish a partnership with a total investment of 50.1 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688065":1},"content_text":"财中社12月16日电凯赛生物（688065）发布公告，拟与创科生物及上海曜建共同投资设立曜酰生物技术(上海)合伙企业，合计出资额为5010万元。其中，公司出资2550万元，占比50.9%；创科生物出资2450万元，占比48.9%；上海曜建出资10万元，占比0.2%。设立的合伙企业将专注于生物基聚酰胺复合材料的研发、生产与销售。此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对2024年度的经营业绩产生重大影响，且不损害上市公司及股东的利益。合伙企业的设立是基于公司与招商局创新科技及合肥市政府的战略合作协议，旨在推动生物基聚酰胺复合材料的产业化。2024年前三季度，凯赛生物实现收入22.15亿元，归母净利润3.45亿元。文章来源：财中社原标题：凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491161514"}

凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元

精彩评论

凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业合计出资额5010万元